3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma
58
Multiple Myeloma
52
Leukemia
48
Leukemia, Myeloid, Acute
44
Precursor Cell Lymphoblastic Leukemia-Lymphoma
41
Myelodysplastic Syndromes
37
Lymphoma, Non-Hodgkin
37
Hodgkin Disease
36
Lymphoma, Mantle-Cell
26
Lymphoma, Large B-Cell, Diffuse
26
Leukemia, Lymphocytic, Chronic, B-Cell
25
Lymphoma, Follicular
22
Breast Neoplasms
22
Burkitt Lymphoma
21
Lymphoma, B-Cell, Marginal Zone
16
Congenital Abnormalities
15
Lymphoma, Large-Cell, Immunoblastic
14
Recurrence
13
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
13
Sarcoma
12
Neoplasms, Plasma Cell
12
Hematologic Neoplasms
10
Leukemia, Myelomonocytic, Juvenile
9
Leukemia, Biphenotypic, Acute
9
Blast Crisis
9
Neoplasms
8
Myeloproliferative Disorders
8
Leukemia, Myelomonocytic, Chronic
8
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
7
Neuroblastoma
7
Interventions
Valganciclovir
3
Specimen Handling
3
Magnetic Resonance Spectroscopy
3
Biopsy
3
Bevacizumab
3
technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran
2
Nivolumab
2
tocilizumab
1
pomalidomide
1
pembrolizumab
1
liposomal doxorubicin
1
emvododstat
1
efineptakin alfa
1
cabozantinib
1
Zidovudine
1
Sunitinib
1
Polymerase Chain Reaction
1
Nelfinavir
1
Maraviroc
1
Lenalidomide
1
Ipilimumab
1
Immunohistochemistry
1
Imatinib Mesylate
1
HhAntag691
1
Gene Expression Profiling
1
Etoposide
1
Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
1
CTLA-4 Antigen
1
Antiretroviral Therapy, Highly Active
1
2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Sarcoma, Kaposi
×
Filgrastim
×
Clear all
No trials found.